FRX - Stock Quote for Forest Laboratories Inc

|CustomizeFRX quote (NYSE Exchange)

31.10 +0.41 +1.34%
After Hours: 31.15 +0.05/+0.16% Vol. 100,400
Previous Close	30.69	Bid	27.45
Open	30.66	Bid Size	1,000
Day's High	31.14	Ask	NA
Day's Low	30.65	Ask Size	NA
Volume	2.64 Mil	52 Week High	30.56
Avg. Daily Vol. (13 wk.)	2.55 Mil	52 Week Low	18.37

FRX Intraday Chart

5d 1m 3m 1y 3y 5y 10y

Beta	0.82
Dividend & Yield	NA
Earnings/Share	2.41
Forward P/E	8.23
Market Cap.	9.38 Bil
P/E	12.85
Return on Equity	17.19
Total Shares Out.	301.77 Mil

Quotes delayed 15 min unless otherwise indicated

Last trade (extended hours) 11/25/2009 5:16 PM ET Financial data in U.S. dollars

Your latest quotes: SHY, FRX, BE:ABI, CALD, HNZ, PGI

News about FRX

Market Report -- Short Stories (FRX) 11/18/2009 Briefing.com
4-Star Stocks Poised to Pop: Alkermes 11/17/2009 Motley Fool
Cypress Bioscience takes bigger loss as costs rise 11/9/2009 Associated Press
View all FRX news

Press releases

Ironwood and Forest Announce Positive Linaclotide Results from Two Pivotal Phase 3 Trials in Patients with Chronic Constipation 11/2/2009 Business Wire
Forest Laboratories, Inc. and Gedeon Richter Announce Positive Results from a Phase IIb Study of Cariprazine for the Treatment of Schizophrenia 10/28/2009 Business Wire
View all FRX news

News from the Web

12 Companies With Ironclad Balance Sheets 12 hours ago At Motley Fool
Top Takes From RealMoney 11/23/2009 At TheStreet.com
Transcript: The Bulls And The Bears 11/23/2009 At Forbes
View all FRX news

Videos about FRX

Advances in Biotechs

Ariad's scarcoma drug, I-Flow acquires Acrymed for acute care services, Forest Lab's drug for schizophrenia and bi-polar disorders, Curis targets cancer